DIDO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.900000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.517600E-01
Normal-vs-Stage2
3.603000E-01
Normal-vs-Stage3
2.948600E-01
Normal-vs-Stage4
9.606800E-01
Stage1-vs-Stage2
6.557800E-01
Stage1-vs-Stage3
1.788170E-01
Stage1-vs-Stage4
5.485200E-01
Stage2-vs-Stage3
2.906600E-01
Stage2-vs-Stage4
3.397000E-01
Stage3-vs-Stage4
2.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.112200E-01
Normal-vs-AfricanAmerican
4.546400E-01
Normal-vs-Asian
4.765600E-01
Caucasian-vs-AfricanAmerican
1.109960E-01
Caucasian-vs-Asian
7.675200E-01
AfricanAmerican-vs-Asian
6.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.755000E-01
Normal-vs-Female
1.895020E-01
Male-vs-Female
4.471700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.341400E-01
Normal-vs-Age(41-60Yrs)
4.977200E-01
Normal-vs-Age(61-80Yrs)
3.788400E-01
Normal-vs-Age(81-100Yrs)
3.460600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.496200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.224400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.230400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.601200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.175200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.035400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.283800E-01
Normal-vs-Daily Drinker
3.804400E-01
Normal-vs-Weekly Drinker
2.828600E-01
Normal-vs-Occasional Drinker
7.524200E-01
Normal-vs-Social Drinker
7.159000E-01
Non Drinker-vs-Daily Drinker
9.785600E-01
Non Drinker-vs-Weekly Drinker
6.602000E-01
Non Drinker-vs-Occasional Drinker
2.299600E-01
Non Drinker-vs-Social Drinker
3.841400E-01
Daily Drinker-vs-Weekly Drinker
7.127000E-01
Daily Drinker-vs-Occasional Drinker
2.789800E-01
Daily Drinker-vs-Social Drinker
4.310000E-01
Weekly Drinker-vs-Occasional Drinker
1.824240E-01
Weekly Drinker-vs-Social Drinker
3.062200E-01
Occasional Drinker-vs-Social Drinker
8.619400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.227420E-01
Normal-vs-Grade 2
7.578000E-03
Normal-vs-Grade 3
2.310500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.472800E-01
Grade 1-vs-Grade 3
1.544980E-01
Grade 1-vs-Grade 4
1.227420E-01
Grade 2-vs-Grade 3
5.854400E-02
Grade 2-vs-Grade 4
7.578000E-03
Grade 3-vs-Grade 4
2.310500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.856610E-01
Normal-vs-NonDiabetic
5.137600E-01
Diabetic-vs-NonDiabetic
1.249810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.940400E-01
Normal-vs-NoPancreatitis
3.711000E-01
Pancreatitis-vs-NoPancreatitis
1.613180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.388800E-01
Normal-vs-N1
2.560600E-01
N0-vs-N1
1.792620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.177200E-01
Normal-vs-TP53-NonMutant
4.805200E-01
TP53-Mutant-vs-TP53-NonMutant
1.716380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
